glp-1 drug least chemical modification Comparing Ozempic, Wegovy and Other Drugs GLP-1-based therapies for type 2

In addition, SGLT-2 inhibitors have shown benefit in patients with both HFrEF and HFpEF independently of diabetes status, which opens exciting possibilities for the use of these therapies in patients at risk for or with established CV or kidney disease without T2D

Disadvantages, compared to sitagliptin, include an injectable dosage form and gastrointestinal side effects

Surprisingly discontinuation rates are also high in diabetics, a study suggests upto 47% diabetics are going off these drugs in just 1 year

So they can pretend theyre watching

Heres the good news: GLP-1 weight loss medications have been clinically proven to be effective in helping people shed unwanted pounds

We now know that GLP-1 medications can have an impact on the skin and hair